Ilginatinib hydrochloride
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM) .
Product Specifications
CAS Number
1239358-85-0
Product Name Alternative
NS-018 hydrochloride
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NS-018-hydrochloride.html
Purity
98.92
Solubility
DMSO : ≥ 35 mg/mL|H2O : 2 mg/mL (ultrasonic)
Smiles
[H]Cl.CN1N=CC(C2=CC(N[C@H](C3=CC=C(F)C=C3)C)=NC(NC4=NC=CN=C4)=C2)=C1
Molecular Formula
C21H21ClFN7
Molecular Weight
425.89
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
JAK1; JAK2; JAK3; Tyk2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
8- (8- Amino- 3, 6- dioxaoctylamino) adenosine- 3', 5'- cyclic monophosphate (8-ADOA-cAMP)
INVICTUS 31 Cu Ft Drosophila Incubator
Polyclonal Antibody to Cytochrome P450 3A4 (CYP3A4)
Polyclonal Antibody to Cytochrome P450 3A4 (CYP3A4)
Polyclonal Antibody to Cytochrome P450 3A4 (CYP3A4)